Regado Biosciences, Inc. is a biopharmaceutical company focused on the discovery and development of novel, first-in-class, actively controllable antithrombotic drug systems for acute and sub-acute cardiovascular indications. Regado is pioneering the discovery and development of two-component drug systems consisting of a therapeutic aptamer and its specific active control agent. The company’s lead product candidate, REG1, is an actively controllable anticoagulant targeting coagulation Factor IXa for use in patients with a wide variety of acute coronary syndromes, or ACS, undergoing a percutaneous coronary intervention, or PCI, a hospital-based procedure used to mechanically open or widen obstructed coronary arteries. The actively controllable product candidates have the potential to improve outcomes, enhance the patient experience and reduce overall treatment costs.

Research Grants 1 show all


$98.5K
2004

Patents 88show all

  • 25
    C12N - Microorganisms or enzymes
  • 22
    A61K - Preparations for medical, dental, or toilet purposes
  • 21
    C07H - Sugars
  • 10
    C12Y - Enzymes
  • 8
    Y02P - Climate change mitigation technologies in the production or processing of goods
  • 4
    C07K - Peptides
  • 2
    C12Q - Measuring or testing processes involving enzymes, nucleic acids or microorganisms

Clinical Trials 22show all

16N/A3Phase 32Phase 21Other

SEC Filings show all


45
8-K

9
10-Q

6
D

3
10-K

1
S-1

Contact Information

Bernards, NJ
United States

SEC Form D Funding Events

DateOfferedSoldType
2014-02-25$20,000,000$20,000,000Equity
2013-01-17$50,780,221$22,634,958Equity, Other
2012-05-21$13,561,080$6,780,540Equity, Debt, Other
2011-07-01$11,599,999$11,599,999Equity, Other
2011-07-01$40,000,000$40,000,000Equity, Other
2007-03-27Unknown Unknown Other (Paper Filing)

Key Executives

  • David J Mazzo
    Executive Officer, Director
  • Jesse Treu
    Director
  • P. Sherrill Neff
    Director
  • Jeff Clark
    Director
  • Raphael Wishiewski
    Director
  • Dennis Podlesak
    Executive Officer, Director
  • B. Jefferson Clark
    Director
  • Dennis J. Podlesak
    Executive Officer, Director
  • Anton Gopka
    Director
  • David J. Mazzo
    Executive Officer, Director
  • Raphael Wisniewski
    Director
  • Michael Mendelsohn
    Director
  • Pierre Legault
    Director
  • Chris Courts
    Executive Officer
  • Michael Metzger
    Executive Officer